Literature DB >> 1709120

Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis.

E Thoreau1, B Petridou, P A Kelly, J Djiane, J P Mornon.   

Abstract

Sequence comparison based on Hydrophobic Cluster Analysis procedures shows that the extracellular approximately 200 amino acids domains of cytokines receptors belonging to the Cytokine/Growth hormone/Prolactin receptor family and to the Interferon one are organized in two homologous subdomains. Further, comparison of the subdomains of 32 independent sequences and of a lot of already recognized homologous domains with data bases could lead to the hypothesis that these approximately 100 amino acids subdomains could possess the overall fold of the constant immunoglobulin domains and so could belong to the immunoglobulin superfamily.

Mesh:

Substances:

Year:  1991        PMID: 1709120     DOI: 10.1016/0014-5793(91)80437-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).

Authors:  S V Kotenko; S Saccani; L S Izotova; O V Mirochnitchenko; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; C Lee; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 4.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

5.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

6.  Prolactin and prolactin receptors are expressed and functioning in human prostate.

Authors:  M T Nevalainen; E M Valve; P M Ingleton; M Nurmi; P M Martikainen; P L Harkonen
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

7.  The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development.

Authors:  I Callebaut; J P Mornon
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

8.  Homology model of human interferon-alpha 8 and its receptor complex.

Authors:  M H Seto; R N Harkins; M Adler; M Whitlow; W B Church; E Croze
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

9.  Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.

Authors:  D S Finbloom; E F Petricoin; R H Hackett; M David; G M Feldman; K Igarashi; E Fibach; M J Weber; M O Thorner; C M Silva
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck.

Authors:  G A Evans; O M Howard; R Erwin; W L Farrar
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.